Answer Summary

Members shared their varied experiences with HIV medication regimens, with several reporting they have been on successful treatments like... Read more

Members shared their varied experiences with HIV medication regimens, with several reporting they have been on successful treatments like Biktarvy for many years while others described cycling through multiple regimens due to developing resistance or reduced effectiveness over time. Many community members expressed deep concern about the financial burden of medications, with costs ranging from fully covered by Medicaid to as high as $1,200 monthly through Medicare Part D, prompting discussions about patient assistance programs like ADAP and eligibility requirements that vary by state. A recurring theme was the anxiety about future treatment options and long-term medication access, balanced by gratitude for programs that help cover costs and relief when a regimen finally works without signs of resistance.